<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><meta http-equiv="Content-Language" content="en" /><title>Verbatim report of proceedings - New psychoactive substances (A7-0172/2014 - Jacek Protasiewicz) - Thursday, 17 April 2014</title><meta name="title" content="Verbatim report of proceedings - New psychoactive substances (A7-0172/2014 - Jacek Protasiewicz) - Thursday, 17 April 2014" /><meta name="language" content="en" /><meta name="robots" content="index, follow, noodp, noydir, notranslate" /><meta name="copyright" content="© European Union, 2014 - Source: European Parliament" /><meta name="available" content="17-04-2014" /><meta name="sipade-leg" content="7" /><meta name="sipade-type" content="CRE" /><meta property="og:title" content="Verbatim report of proceedings - New psychoactive substances (A7-0172/2014 - Jacek Protasiewicz) - Thursday, 17 April 2014" /><meta property="og:image" content="https://www.europarl.europa.eu/website/common/img/icon/sharelogo_facebook.jpg" /><link rel="canonical" href="https://www.europarl.europa.eu/doceo/document/CRE-7-2014-04-17-ITM-010-09_EN.html" /><link href="/doceo/data/css/style_common.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_common_print.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_sipade.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/style_activities.css" rel="stylesheet" type="text/css" /><link href="/doceo/data/css/common_sides.css" type="text/css" rel="stylesheet" /><link href="/doceo/data/css/style_sipade_oj_sched.css" type="text/css" rel="stylesheet" />
<script src="/doceo/data/js/overlib.js" type="text/javascript"> </script>
<script src="/doceo/data/js/swap_images.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade.js" type="text/javascript"> </script>
<script src="/doceo/data/js/jquery-1.4.4.js" type="text/javascript"> </script>
<script src="/doceo/data/js/sipade-OJ-SYN.js" type="text/javascript"> </script><!--ATI analytics script--><script type="text/javascript" data-tracker-name="ATInternet" defer data-value="/website/webanalytics/ati-doceo.js" src="//www.europarl.europa.eu/website/privacy-policy/privacy-policy.js" ></script></head><body bgcolor="#FFFFFF"><div id="overDiv" style="position:absolute; visibility:hidden; z-index:1000;"> </div><a name="top"></a><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td><div id="header_sides" class="new">
<a href="/portal/en"><img alt="Go back to the Europarl portal" title="Go back to the Europarl portal" src="/doceo/data/img/EP_logo_neg_EN.png" /></a><h3 class="ep_hidden">Choisissez la langue de votre document :</h3><ul class="language_select">
            <li><a title="bg - български" class="bg on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_BG.html">bg - български</a></li>
            <li><a title="es - español" class="es on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_ES.html">es - español</a></li>
            <li><a title="cs - čeština" class="cs on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_CS.html">cs - čeština</a></li>
            <li><a title="da - dansk" class="da on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_DA.html">da - dansk</a></li>
            <li><a title="de - Deutsch" class="de on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_DE.html">de - Deutsch</a></li>
            <li><a title="et - eesti keel" class="et on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_ET.html">et - eesti keel</a></li>
            <li><a title="el - ελληνικά" class="el on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_EL.html">el - ελληνικά</a></li>
            <li class="en selected" title="en - English">en - English<span> (Selected)</span></li>
            <li><a title="fr - français" class="fr on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_FR.html">fr - français</a></li>
            <li class="ga" title="ga - Gaeilge">ga - Gaeilge</li>
            <li><a title="hr - hrvatski" class="hr on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_HR.html">hr - hrvatski</a></li>
            <li><a title="it - italiano" class="it on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_IT.html">it - italiano</a></li>
            <li><a title="lv - latviešu valoda" class="lv on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_LV.html">lv - latviešu valoda</a></li>
            <li><a title="lt - lietuvių kalba" class="lt on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_LT.html">lt - lietuvių kalba</a></li>
            <li><a title="hu - magyar" class="hu on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_HU.html">hu - magyar</a></li>
            <li><a title="mt - Malti" class="mt on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_MT.html">mt - Malti</a></li>
            <li><a title="nl - Nederlands" class="nl on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_NL.html">nl - Nederlands</a></li>
            <li><a title="pl - polski" class="pl on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_PL.html">pl - polski</a></li>
            <li><a title="pt - português" class="pt on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_PT.html">pt - português</a></li>
            <li><a title="ro - română" class="ro on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_RO.html">ro - română</a></li>
            <li><a title="sk - slovenčina" class="sk on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_SK.html">sk - slovenčina</a></li>
            <li><a title="sl - slovenščina" class="sl on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_SL.html">sl - slovenščina</a></li>
            <li><a title="fi - suomi" class="fi on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_FI.html">fi - suomi</a></li>
            <li><a title="sv - svenska" class="sv on" href="/doceo/document/CRE-7-2014-04-17-ITM-010-09_SV.html">sv - svenska</a></li>
        </ul></div></td></tr><tr><td style="padding:10px;"><table width="100%" border="0" cellspacing="0" cellpadding="0"><tr><td><table border="0" align="left" cellpadding="0" cellspacing="0"><tr><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-7-2014-04-17-TOC_EN.html"><img src="/doceo/data/img/navi_index.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-7-2014-04-17-TOC_EN.html" title="Index">Index</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-7-2014-04-17-ITM-010-08_EN.html"><img src="/doceo/data/img/navi_previous.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-7-2014-04-17-ITM-010-08_EN.html" title="Previous">Previous</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td valign="middle"> <a href="/doceo/document/CRE-7-2014-04-17-ITM-010-10_EN.html" title="Next">Next</a> </td><td><a href="/doceo/document/CRE-7-2014-04-17-ITM-010-10_EN.html"><img src="/doceo/data/img/navi_next.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td><td><table border="0" cellspacing="0" cellpadding="0" class="buttondocwin"><tr><td><a href="/doceo/document/CRE-7-2014-04-17_EN.html"><img src="/doceo/data/img/navi_moredetails.gif" width="16" height="16" border="0" align="absmiddle" alt="" /></a></td><td valign="middle"> <a href="/doceo/document/CRE-7-2014-04-17_EN.html" title="Full text">Full text</a> </td></tr></table></td><td><img src="/doceo/data/img/spacer.gif" width="10" height="8" alt="" /></td></tr><tr><td><img src="/doceo/data/img/spacer.gif" width="10" height="15" alt="" /></td></tr></table></td></tr></table>
                <table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td align="left"><span class="contents">Procedure : </span><a class="ring_ref_link" href="https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&amp;reference=2013/0305(COD)">2013/0305(COD)</a></td><td align="right"><table align="right" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><img src="/doceo/data/img/ring_tabs_left_doc_unselected.gif" height="19" width="4" alt="" /></td><td class="Tabs_doc_unselected"><img src="/doceo/data/img/ring_navi.gif" width="17" height="14" alt="" />Document stages in plenary</td><td valign="middle"><img src="/doceo/data/img/ring_tabs_right_doc_unselected.gif" height="19" width="4" alt="" /></td></tr></tbody></table></td></tr></tbody></table><table class="doc_box_header" border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr><td class="ring_multiple_bg" valign="top" colspan="7">Document selected :
            <span class="ring_ref_selected_header">A7-0172/2014</span></td></tr><tr><td width="25%" valign="top" class="ring_step_bg1" nowrap="nowrap"><p class="ring_step_title">Texts tabled :</p>
                        <a href="/doceo/document/A-7-2014-0172_EN.html" class="ring_ref_link">A7-0172/2014</a><br />
                    </td><td width="15" style="background-image:url(/doceo/data/img/ring_bg1.gif)"><img src="/doceo/data/img/ring_flech1.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg2" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Debates :</p></td><td width="15" style="background-image:url(/doceo/data/img/ring_bg2.gif)"><img src="/doceo/data/img/ring_flech2.gif" width="13" height="22" border="0" alt="" /></td><td class="ring_step_bg3" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Votes :</p>
                        <a href="/doceo/document/PV-7-2014-04-17-ITM-009-09_EN.html" class="ring_ref_link">PV 17/04/2014 - 9.9</a><br />
                        <a class="ring_ref_selected">Explanations of votes</a><br />
                    </td><td width="19" style="background-image:url(/doceo/data/img/ring_bg3.gif)"><img src="/doceo/data/img/ring_flech3.gif" height="22" width="13" border="0" alt="" /></td><td class="ring_step_bg4" valign="top" width="25%" nowrap="nowrap"><p class="ring_step_title">Texts adopted :</p>
                        <a href="/doceo/document/TA-7-2014-0453_EN.html" class="ring_ref_link">P7_TA(2014)0453</a><br />
                    </td></tr></tbody></table><br />
            <table width="100%" border="0" cellpadding="5" cellspacing="0" class="doc_box_header">
<tr>
<td align="left" valign="top" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="title_TA">Verbatim report of proceedings</td><td valign="top" align="right" style="background-image:url(/doceo/data/img/gradient_blue.gif)"></td>
</tr>
<tr>
<td class="doc_title" align="left" valign="top" bgcolor="#F5F5F5">Thursday, 17 April 2014 - Strasbourg</td>
<td class="doc_title" align="right" valign="top" bgcolor="#F5F5F5">Revised edition</td></tr></table><br />
<table width="100%" border="0" cellpadding="0" cellspacing="0" class="doc_box_header" style="padding-bottom:5px"><tr valign="top"><td>
<table width="100%" border="0" cellpadding="5" cellspacing="0"><tr valign="top" style="padding-bottom:0px;padding-left:5px;padding-right:5px;padding-top:5px"><td align="left" style="background-image:url(/doceo/data/img/gradient_blue.gif)" class="doc_title"><img src="/doceo/data/img/arrow_title_doc.gif" width="8" height="14" border="0" align="absmiddle" alt="" /> 10.9. New psychoactive substances (<a href="/doceo/document/A-7-2014-0172_EN.html">A7-0172/2014</a> - Jacek Protasiewicz) </td></tr></table>
<a name="4-175-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><span class="bold">Explications de vote par écrit</span></p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-250"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118860.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Claudette Abela Baldacchino (S&amp;D), </span></span>  <span class="italic">in writing. - </span>This is a very important dossier. The rising number of new psychoactive substances available in the EUʼs internal market, their growing diversity, both in type and risk level, the speed with which they emerge and the growing number of individuals who consume them, challenge the capacity of public authorities to provide effective responses to protect public health and safety without hampering legitimate trade. New psychoactive substances can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer ‘Youth attitudes on drugsʼ, 5[nbsp ]% of young people in the EU have used such substances at least once in their life, with a peak of 16[nbsp ]% in Ireland, and close to 10[nbsp ]% in Poland, Latvia and the United Kingdom. The consumption of new psychoactive substances can cause harm to the health and safety of individuals and can pose risks and burdens for society as it may lead to violent behaviour and crime. If we truly believe in a Social Europe where everybody matters we need to stress even more the social aspect of society through the ‘respect yourselfʼ notion. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-312"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96976.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Luís Paulo Alves (S&amp;D), </span></span>  <span class="italic">por escrito</span>. <span class="bold">-</span> Aprovo o presente relatório, tendo em conta que as novas substâncias psicoativas são substâncias com os mesmos efeitos de substâncias controladas, mas que não são abrangidas pelas Convenções das Nações Unidas para o Controlo das Drogas. Muitas delas podem ter utilizações comerciais e industriais, bem como ser exploradas para fins científicos e de desenvolvimento. Quando consumidas por seres humanos, podem apresentar riscos para a saúde, para a sociedade e para a segurança. Nas últimas décadas, verificou-se um rápido aumento das vendas e do consumo dessas substâncias em muitos Estados-Membros. Há dados que demonstram que as novas substâncias psicoativas são especialmente populares entre os grupos etários mais jovens. Segundo o inquérito do Eurobarómetro <span class="italic">Atitudes dos Jovens perante a Droga</span>, de 2011, 5% dos jovens da UE consumiram estas substâncias pelo menos uma vez na vida; a percentagem máxima, de 16%, registou-se na Irlanda, tendo a Polónia, a Letónia e o Reino Unido registado valores próximos dos 10%. São mais de 300 as novas substâncias psicoativas utilizadas, hoje em dia, em toda a Europa. Atualmente, as novas notificações apresentadas pelos Estados-Membros ocorrem a um ritmo de, aproximadamente, uma por semana.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-343"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/1941.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Roberta Angelilli (PPE), </span></span>  <span class="italic">per iscritto</span><span class="bold">. -</span> Dall´analisi dei recenti dati sull´utilizzo delle sostanze psicoattive, si è resa necessaria un´azione più efficace e meglio coordinata tra gli Stati membri e le agenzie dell´UE in relazione all´utilizzo delle stesse. La presente proposta di regolamento è accolta con favore, dal momento che stabilisce un sistema di scambio rapido di informazioni sulle nuove sostanze psicoattive che compaiono sul mercato, anche sul loro utilizzo commerciale e industriale, per valutare i rischi di quelle che suscitano preoccupazioni a livello dell´UE e per ritirare dal mercato quelle che comportano rischi. Dobbiamo prevenire i rischi sociali, di salute e di sicurezza che queste sostanze possono provocare, e attraverso tale regolamento potremo garantire una risposta efficace e strutturale al problema in questione.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-359"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96862.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sophie Auconie (PPE), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> J'ai voté en faveur de ce texte qui gère la procédure de contrôle des nouvelles substances psychoactives au niveau de l'Union. Elles sont classées selon qu'elles présentent des risques faibles, modérés ou sérieux: le règlement porte sur la classification elle-même tandis que la directive définit les dispositions pénales qui s'appliquent aux substances présentant des risques sérieux frappées d'une restriction de marché permanente.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-367"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/107041.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Heinz K. Becker (PPE), </span></span>  <span class="italic">schriftlich</span>. <span class="bold">-</span> Der Verbrauch von konventionellen Drogen wie Kokain und Ecstasy nimmt zwar ab, dafür drängen immer mehr neue Substanzen, die legal verkauft werden können, auf den Markt. Drogen unter dem Deckmantel „Düngemittel“, „Badesalz“, „pflanzliches Lebensmittel“ und Co. sind aber mindestens so gefährlich. Mit dem heutigen Beschluss können wir schneller auf neue „Designerdrogen“ reagieren und ihnen einen Riegel vorschieben!</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/97198.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Mara Bizzotto (EFD), </span></span>  <span class="italic">per iscritto. - </span>Condivido le posizioni sostenute nella relazione che analizza il regolamento sulle nuove sostanze psicoattive, ritengo che l'armonizzazione della normativa a livello europeo e la creazione di un registro unico faciliteranno la gestione di tali sostanze in tutti gli Stati membri.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/29074.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Vito Bonsignore (PPE), </span></span>  <span class="italic">per iscritto. - </span>Oltre 200 sostanze con effetti psicoattivi pericolosi sono agevolmente reperibili nelle città europee, per non parlare del commercio internazionale, alimentato da una vivace blogosfera di entusiasti utilizzatori abituali, improbabili teorici della ribellione, veri e propri business dell’intermediazione. Oltre alle sostanze derivate da estratti vegetali, largamente disponibili ai consumatori, la minaccia immediata ed evidente è data dall’abuso di medicinali (in particolare analgesici di alcune categorie) e dalla diffusione dei precursori.</p>
<p class="contents">L’UE ha da tempo adottato una filosofia volta non a criminalizzare l’utilizzo da parte degli individui di singole sostanze, ma a valutarne l’impatto sulla società in base a risultanze scientifiche ed epidemiologiche oggettive, al fine di tutelare l’incolumità dei cittadini che è iscritta tra i valori della carta fondamentale europea. </p>
<p class="contents">Va anche combattuta la banalizzazione dei rischi sociali derivanti da un uso inconsapevole di tali sostanze.</p>
<p class="contents">Va a merito dell’UE il farsi carico tempestivamente di questa nuova sfida alla salute degli Europei attraverso un regolamento equilibrato e flessibile, fortemente ancorato ai principi di proporzionalità e sussidiarietà, che fornisce gli strumenti per una risposta efficace ed immediata, e nel contempo istituisce importanti automatismi nello scambio di informazioni tra le autorità interessate dalle attività di ricerca scientifica, categorizzazione normativa ed applicazione della regolamentazione. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/111126.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Arkadiusz Tomasz Bratkowski (PPE), </span></span>  <span class="italic">na piśmie. - </span>Chciałbym wyrazić zadowolenie z wyniku prac nad rozporządzeniem w sprawie nowych substancji psychoaktywnych oraz dyrektywą wyznaczającą minimalne przepisy określające znamiona przestępstw i kar w dziedzinie nielegalnego handlu narkotykami w odniesieniu do definicji narkotyków. Oba te sprawozdania były ze sobą ściśle powiązane, gdyż dyrektywa wprowadziła także minimalne przepisy w zakresie rozporządzenia. Wspomniane akty łączy procedura, dzięki której nowe substancje psychoaktywne będą podlegać kontroli na poziomie unijnym za sprawą klasyfikacji według małego, umiarkowanego i wysokiego ryzyka. Jestem zdania, iż stanowisko przyjęte przez Parlament Europejski jest niezmiernie istotne z racji rozbieżności przepisów krajowych państw członkowskich UE oraz potrzeby zapewnienia ścisłej kontroli nowych substancji psychoaktywnych, w tym karania czynów związanych z ich rozprowadzaniem w celu zapewnienia skutecznej ochrony naszej młodzieży i ogółu społeczności.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96993.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Lorenzo Fontana (EFD), </span></span>  <span class="italic">per iscritto. - </span>La relazione mira a regolamentare il sempre più diffuso malcostume del consumo di quelle che vengono definite “nuove sostanze psicoattive”, ovvero sostanze chimiche di nuova generazione ad uso commerciale e industriale.</p>
<p class="contents">Esse riproducono gli effetti di alcune droghe, il loro consumo è altamente dannoso per la salute degli individui e la loro commercializzazione sotto mentite spoglie di profumi per l’ambiente e fertilizzanti, costituisce un pericolo a livello di salute pubblica e sociale.</p>
<p class="contents">Per i motivi qui esposti esprimo voto favorevole</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-175-937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/2125.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Pat the Cope Gallagher (ALDE), </span></span>  <span class="italic">in writing</span><span class="bold">. -</span> While we generally support the objective of the proposal, we believe that the final agreement must better reflect a public health objective rather than a focus on market harmonisation. We also strongly support the principle that Member States may introduce further measures to deal with the specific risks that these substances pose to citizens.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-000"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96707.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Ágnes Hankiss (PPE), </span></span>  <span class="italic">írásban</span><span class="bold">. -</span> Vitathatatlan tény, hogy az új pszichoaktív anyagok fogyasztása jelentős szociális és egészségügyi kockázatokat jelent a civil társadalom számára, ráadásul gyakran erőszakos viselkedéshez és bűnelkövetéshez vezethet. Szomorú, hogy a 2011. évi Eurobarométer gyorsfelmérése alapján a fiatalok 5%-a már használt ilyen tudatmódosító szereket. Az EU-nak meg kell akadályoznia, hogy ezek a szerek a piacra kerüljenek és akár legálisan vagy illegálisan hozzáférhetőek legyenek. A fellépést ellenük nehezíti, hogy ezeket az anyagokat többségükben az ipar legálisan felhasználhatja, (például vegyipar, gyógyszeripar, csúcstechnológiai ipar) értékesítésük pedig az Interneten keresztül történik. A tagállamok különböző módon kezelik ezt a veszélyes jelenséget, ami azt eredményezheti, hogy a feketepiacon keresztül juttatják el ezeket a szereket egyik országból a másikba. Ezért tartom támogatandónak az uniós szintű fellépést az új típusú pszichoaktív anyagok térhódításával szemben.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-125"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96959.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">George Lyon (ALDE), </span></span>  <span class="italic">in writing</span><span class="bold">. -</span> I did not vote in favour of the report on psychoactive substances today. While I agree that we need to address the issue of legal highs, I feel that the current proposal does not allow Member States the flexibility required to respond swiftly and effectively to this fast-changing market. The profileration of new psychoactive substances is influenced by regional, national, international, social, economic and other factors meaning that each Member State may be affected differently and have different issues to face in this respect. Therefore, while cooperation is welcome on an EU level, Member States themselves are best placed to deal with problems concerning psychoactive substances which may be prevalent on their territory.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-187"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23704.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jiří Maštálka (GUE/NGL), </span></span>  <span class="italic">písemně</span><span class="bold">. -</span> Jak bylo deklarováno také v odůvodnění návrhu, nárůst nových psychoaktivních látek a jejich dostupnost na vnitřním trhu Evropské unie s sebou přináší také nutnost efektivní reakce příslušných orgánů v rámci ochrany zdraví občanů. Zároveň je však potřebné zachovat legální trh s těmito látkami a umožnit jejich kontrolované použití například pro vědecké účely. Návrh vhodně zapracovává detekci nových psychoaktivních látek na trhu, zabývá se stanovením a vyhodnocením míry rizik. Ačkoliv pokládám návrh za velmi prospěšný, a to jak z pohledu poslance, tak z pohledu lékaře, považuji za poněkud problematické části týkající se pravomocí Komise. Z těchto důvodů jsem se při konečném hlasování zdržel.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-218"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96742.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Jean-Luc Mélenchon (GUE/NGL), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> Les substances psychoactives sont des substances agissant sur l'état du système nerveux central en y modifiant certains processus biochimiques et physiologiques cérébraux. En altérant de la sorte les fonctions du cerveau, elles induisent des modifications de la perception, des sensations, de l'humeur, de la conscience (états modifiés de conscience) ou d'autres fonctions psychologiques et comportementales. Ces substances peuvent être détournée de leur usage initial (industriel, médical, etc). Je note qu'une grande attention est accordée aux substances psychoactives qui échappent au marché capitaliste. Il est fort dommage que le même intérêt ne soit pas porté aux substances psychoactives légales, prescrites et sur-consommées en Europe. Les conséquences en terme de santé publique sont pourtant proches, voire pire. En France 1 personne sur 10 a consommé des psychoactifs médicaux dans l'année. Le problème, dans ce cadre, y est donc bien plus vaste que les 5% de jeunes européens ayant consommé de la "drogue" une fois dans leur vie. Avant de s'attaquer aux consommations illégales il serait bon de se pencher sur les consommations subventionnées par les systèmes sociaux au profit des laboratoires pharmaceutiques. Je vote contre ce texte hypocrite qui n'ose pas s'attaquer aux principaux pourvoyeurs de substances psychoactives.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-234"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118859.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Roberta Metsola (PPE), </span></span>  <span class="italic">in writing</span><span class="bold">. - </span>The presence of new psychoactive substances in the EU requires a robust policy framework to deal with the various complexities it raises. It is vital that Europe establish a unified position on what needs to be done to combat their use. It is for this reason therefore that I voted in favour of the report.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-242"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/28407.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Willy Meyer (GUE/NGL), </span></span>  <span class="italic">por escrito</span><span class="bold">. -</span> Cada vez más, nuevas sustancias psicotrópicas emergen y se distribuyen por la UE. Por ello la Comisión hace propuestas para un sistema más rápido de prevención de nuevas sustancias dañinas y para un enfoque gradual que responda a los riesgos de las mismas. A pesar de esta necesidad, no puedo votar a favor del informe sobre la propuesta de la Comisión puesto que las sustancias psicotrópicas son primordialmente un problema de salud pública y, por tanto, las consideraciones comerciales deberían quedar al margen, especialmente cuando el tema está íntimamente ligado a legislación penal. Por ello he votado contra el informe.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-246"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/118858.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Marlene Mizzi (S&amp;D), </span></span>  <span class="italic">in writing</span><span class="bold">. -</span> I voted in favour of this report, which proposes establishing a robust form of information exchange between the Member States, the European Monitoring Centre on Drugs and Drug Addiction, Europol and the Commission.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-310"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96900.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Georgios Papanikolaou (PPE), </span></span>  <span class="italic">γραπτώς. - </span>Τάχθηκα υπέρ αυτής της έκθεσης, μέσω της οποίας το Ευρωπαϊκό Κοινοβούλιο ενέκρινε το θεσμικό πλαίσιο για τις νέες ψυχότροπες ουσίες που δεν καλύπτονται από τις συμβάσεις των Ηνωμένων Εθνών για τον έλεγχο των ναρκωτικών. Πρόκειται για ουσίες που μπορούν να χρησιμοποιηθούν για εργαστηριακούς ή βιομηχανικούς σκοπούς. Η χρήση αυτών των ουσιών, των οποίων οι επιπτώσεις συνεχίζουν να διερευνούνται, δεν αποκλείεται να επιφυλάσσει τεράστιους κινδύνους για τον άνθρωπο, τόσο προβλήματα υγείας όσο και εκτροπές με κοινωνικές προεκτάσεις. Από τα υπάρχοντα στοιχεία προκύπτει ότι, τα τελευταία χρόνια, οι ουσίες αυτές είναι ιδιαίτερα δημοφιλείς στην ΕΕ και κυρίως μεταξύ ατόμων νεαρής ηλικίας. Συνεπώς και επιπλέον του παρόντος πολύ σημαντικού κειμένου, η ΕΕ καλείται να δράσει άμεσα και αποφασιστικά για την προστασία των πολιτών και ιδιαίτερα της νεολαίας. Σύμφωνα και με την Επιτροπή, η καταπολέμηση των ναρκωτικών αποτελεί μια από τις σημαντικότερες προκλήσεις για την ΕΕ, διότι πρόκειται για ζήτημα δημόσιας υγείας και προστασίας του ατόμου, ζήτημα κοινωνικής συνοχής και ασφάλειας, αλλά και προτεραιότητα στο πλαίσιο της καταπολέμησης του οργανωμένου εγκλήματος. </p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-375"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96948.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Gilles Pargneaux (S&amp;D), </span></span>  <span class="italic">par écrit</span><span class="bold">. –</span> J'ai voté en faveur de ce texte qui renforce la législation de contrôle des substances psychoactives, celle qui ont un effet sur le cerveau et donc les addictions (tabac, alcool, cannabis, etc.). Le texte propose une classification pertinente pour appliquer des restrictions à ces substances en fonction de leurs risques.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-500"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96902.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Maria do Céu Patrão Neves (PPE), </span></span>  <span class="italic">por escrito. - </span>Votei favoravelmente a presente proposta em que se aprova a restrição temporária de comercialização de novas substâncias psicoativas. Trata-se de uma novidade importante no novo mecanismo e que, uma vez adotada pela Comissão, deve manter-se em vigor até que os Estados-Membros apliquem as medidas permanentes. Tendo presente a dinâmica dos fenómenos e optando pela eficiência do sistema, o Parlamento alterou as disposições do artigo 9.º para evitar possíveis descontinuidades entre a restrição temporária da comercialização e a aplicação das medidas permanentes.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-750"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/119441.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sandra Petrović Jakovina (S&amp;D), </span></span>  <span class="italic">napisan</span><span class="bold">. -</span> Nove nepoznate psihoaktivne tvari sve su veća prijetnja europskoj mladeži. Njihovom dostupnošću zbog cijene te činjenicom da nisu uvrštene na listu ilegalnih supstanci mamac su za neupućenu mladež. Statistika koja ukazuje na čak 5% mladih diljem Unije koji su takvu vrstu droge probali zabrinjavajuća je. Nedostatak općeg javnog znanja i svijesti o rizicima povezanim sa njihovim uzimanjem pridonose težini problema. Budući da se spomenute tvari koriste u svrhu istraživanja te u proizvodnji različitih proizvoda kao što su lijekovi i sredstva za čišćenje, njihovo ograničavanje moglo bi ostaviti posljedice na razne industrije, a istovremeno ne bi pridonijelo rješenju zbog brzine javljanja novih tvari na tržištu. </p>
<p class="contents">Od primarne je važnosti stoga utvrditi zajednički odgovor Unije kojim bi se očuvalo zdravlje građana, a u isto vrijeme izbjeglo narušavanje unutrašnjeg tržišta. Stoga sam podržala ovaj prijedlog koji kao cilj ima pružanje potpore i sredstava na razini Unije i nacionalnoj razini kako bi se olakšala redovita i sustavna suradnja između EMCDDA-a, nacionalnih točaka, predstavnika zdravstvene skrbi i tijela za provedbu zakona na nacionalnoj i regionalnoj razini te tijela s relevantnom stručnošću te se time spriječila zlouporaba novih psihoaktivnih tvari i stvorila sigurnija i produktivnija zajednica.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-875"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/112744.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Tonino Picula (S&amp;D), </span></span>  <span class="italic">napisan</span><span class="bold">. -</span> Sve veća raznolikost i brzina s kojom se nove psihoaktivne tvari javljaju na tržištu predstavlja rizik za građane koji nisu u potpunosti upućeni i osviješteni o rizicima povezanim s njihovom konzumacijom. Stoga je važno uspostaviti robusni način razmjene informacija među zemljama članicama, Komisijom i nadležnim agencijama kako bi odlučili o zajedničkoj reakciji na pojavu novih psihoaktivnih supstanci na tržištu. </p>
<p class="contents">Pogotovo je važno imati na umu djecu i mlade koji su posebno ranjiva skupina na opasnosti koje predstavljaju nove psihoaktivne tvari na tržištu čiji rizici još nisu poznati. Zato mi je drago da je Parlament uvrstio amandmane u kojima posebno upozorava na njihovu sigurnost i poziva na nužno upoznavanje djece, adolescenata i mladih s rizicima na školskoj i široj obrazovnoj razini.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-937"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96755.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Sergio Paolo Francesco Silvestris (PPE), </span></span>  <span class="italic">per iscritto</span><span class="bold">. -</span> Alla rapida diffusione di sostanze psicoattive, gli Stati membri hanno risposto con diverse misure di controllo, applicando metodi specifici per ogni Stato che possono provocare l'insorgere di ostacoli al corretto funzionamento del mercato interno. Per tale motivo, la comunicazione della Commissione in materia è ben accetta, in quanto invita l'UE e gli Sati membri a una risposta più decisa e coerente, tramite uno scambio di informazioni più attivo e il ritiro e le restrizioni temporanee per talune sostanze. La lotta contro queste nuove sostanze potrà meglio essere affrontata grazie a questi nuovi strumenti, permettendo un'azione più coordinata, condizione indispensabile alla lotta contro la criminalità organizzata che opera nel settore e che spesso sfrutta reti criminali transnazionali.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-968"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/96920.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Kay Swinburne (ECR), </span></span>  <span class="italic">in writing</span><span class="bold">. -</span> Under this proposal new psychoactive substances that pose severe health, social and safety risks and are subjected to permanent market restriction under the regulation are also subjected to the minimum criminal-law provisions on drug trafficking set by the new directive. The purpose is to avoid problems in Member State cooperation owing to the fact that the offences in question are not punishable under the laws of both the requesting and the requested State.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-984"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/36281.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Silvia-Adriana Ţicău (S&amp;D), </span></span>  <span class="italic">în scris</span><span class="bold">. -</span> Am votat pentru propunerea de regulament privind noile substanțe psihoactive. Numărul crescând de substanțe psihoactive noi disponibile pe piața internă, diversitatea din ce în ce mai mare a acestora, viteza cu care apar pe piață, diferitele riscuri pe care le pot prezenta atunci când sunt consumate de oameni solicită din plin capacitatea autorităților publice de a oferi soluții eficiente de protejare a sănătății și a siguranței publice fără a obstrucționa funcționarea pieței interne. </p>
<p class="contents">Având în vedere diferențele de condiții și circumstanțe din statele membre în ceea ce privește substanțele psihoactive, măsurile de restricționare variază în mod corespunzător de la un stat membru la altul, ceea ce înseamnă că operatorii economici care utilizează substanțe psihoactive noi în producția diferitelor produse trebuie să îndeplinească, în cazul aceleiași substanțe de acest fel, cerințe diferite, cum ar fi notificarea prealabilă exportului, autorizația de export sau licențele de import și export. Prezentul regulament ar trebui să prevadă excepțiile necesare pentru a asigura protecția sănătății oamenilor și a animalelor, a facilita cercetarea și dezvoltarea științifică și a permite utilizarea noilor substanțe psihoactive în industrie, cu condiția ca acestea să nu fie susceptibile de a produce efecte adverse și să nu poată fi utilizate în mod abuziv sau recuperate.</p></td><td width="16"> </td></tr>
<tr><td width="70"> </td><td width="5"> </td><td align="left" valign="bottom"><img src="/doceo/data/img/hr.gif" width="100%" height="1" alt="" /></td><td align="right" width="16"><table border="0" cellpadding="0" cellspacing="0" class="buttondocwin"><tbody><tr><td align="center"><a href="#top" title="Top"><img src="/doceo/data/img/navi_top.gif" width="16" height="16" border="0" alt="" /></a></td></tr></tbody></table></td></tr></table>
<a name="4-176-992"></a>
<table width="100%" border="0" cellpadding="5" cellspacing="0">
<tr><td width="70" align="center" valign="top"><table cellpadding="0" cellspacing="0" class="photoframe_blue"><tr><td><img alt="MPphoto" src="/mepphoto/23894.jpg" align="right" width="50" height="63" onerror="this.onerror='';this.src='/doceo/data/img/photo_generic.gif'" /></td></tr></table> </td><td width="5"> </td><td align="left" valign="top">
<p class="contents"><img src="/doceo/data/img/arrow_summary.gif" align="absmiddle" alt="" />  <span class="doc_subtitle_level1_bis"><span class="bold">Anna Záborská (PPE), </span></span>  <span class="italic">písomne </span><span class="bold">-</span> Podporila som návrh nariadenia o nových psychoaktívnych látkach, pretože predstavujú zdravotné, spoločenské a bezpečnostné riziko. Vo viacerých členských štátoch vrátane Slovenska v posledných rokoch prudko vzrástol ich predaj a konzumácia, najmä medzi mladými ľuďmi. Na rýchly nástup a šírenie týchto látok doposiaľ členské štáty reagovali rôzne, čo viedlo ku komplikáciám pri fungovaní jednotného trhu. Nové nariadenie tento problém rieši. Látky, v ktorých prípade existuje podozrenie, že predstavujú bezprostredné riziko pre verejné zdravie, budú zo spotrebiteľského trhu dočasne stiahnuté, až kým nebude k dispozícii hodnotenie rizika, ktoré vykoná Európske monitorovacie centrum pre drogy a drogovú závislosť. Keď sa hodnotenie rizika ukončí, prijmú sa opatrenia, ktoré budú primerané rizikám spojeným s príslušnými látkami. Tieto opatrenia budú odstupňované podľa toho, či bude riziko ohodnotené ako nízke, mierne alebo závažné.</p></td><td width="16"> </td></tr></table></td></tr></table><table width="100%" border="0" cellspacing="0" cellpadding="5"><tr class="footerdocwin"><td></td><td align="right"><a target="_blank" href="/legal-notice/en">Legal notice</a> - <a target="_blank" href="/privacy-policy/en">Privacy policy</a></td></tr></table></td></tr></table></body></html>
